Astero Bio Sells To BioLife Solutions
BroadOak Capital Partners advised Astero Bio Corporation (“Astero”) on the sale of the company to BioLife Solutions. Astero is a provider of innovative tools that improve the quality of high-value cell and gene therapies. The full press release is below. BioLife Solutions Expands Cell and Gene Therapy Tools Portfolio with Acquisition of Astero Bio Gains […]